Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model

Published:2020-11 Issue: Volume:156 Page:114-120
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Bohr Adam,Tsapis Nicolas,Foged Camilla,Andreana Ilaria,Yang Mingshi,Fattal Elias

Funder

Danish Council for Independent Research

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference41 articles.

1. The COPD pipeline;Mushtaq;Nat. Rev. Drug. Discov.,2014

2. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report;Singh;Eur. Respir. J.,2019

3. Cytokine inhibition in the treatment of COPD;Caramori;Int. J. Chron. Obs. Pulmon Dis.,2014

4. Role of TNFα in pulmonary pathophysiology;Mukhopadhyay;Respir. Res.,2006

5. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed;Feldmann;The Lancet,2020

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Micro and Nanoengineering in Powder-Based Pulmonary Drug Delivery;International Journal of Pharmaceutics;2024-06

2. Fermented lily bulbs by “Jiangshui” probiotics improves lung health in mice;Food Chemistry;2024-05

3. Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome;Colloids and Surfaces B: Biointerfaces;2024-05

4. Current advances in the therapeutic potential of nanomedicines for pulmonary disorders;Emergent Materials;2024-04-24

5. Recent Progress in Nucleic Acid Pulmonary Delivery toward Overcoming Physiological Barriers and Improving Transfection Efficiency;Advanced Science;2024-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3